Oral Cavity Cancer clinical trials

Explore recruiting oral cavity cancer clinical trials.

Recruiting oral cavity cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oral Cavity Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Tolerability and efficacy of treating locally advanced Resectable Oral Cancer with neoadjuvant INtratumoral anti-CTLA4 ImmunoTherapy combined with systemic anti-PD-1 (ROCinIT).

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Oral Cavity Cancer trials by city

Oral Cavity Cancer in Toronto Oral Cavity Cancer in Vancouver Oral Cavity Cancer in Montreal Oral Cavity Cancer in Calgary Oral Cavity Cancer in Edmonton Oral Cavity Cancer in Ottawa Oral Cavity Cancer in Winnipeg Oral Cavity Cancer in Quebec City Oral Cavity Cancer in Hamilton Oral Cavity Cancer in Kitchener Oral Cavity Cancer in London Oral Cavity Cancer in Halifax Oral Cavity Cancer in New York Oral Cavity Cancer in Los Angeles Oral Cavity Cancer in Chicago Oral Cavity Cancer in Houston

Oral Cavity Cancer clinical trials

Recruiting oral cavity cancer studies right now

Quality of Life and Economic Repercussions of Combining Proactive Medication Assessment and Electronic Monitoring of Toxicities in Subjects Undergoing Oral Cancer Therapy

Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer

Enhancing Oral Cancer Awareness

Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

Also recruiting in Europe

Tolerability and efficacy of treating locally advanced Resectable Oral Cancer with neoadjuvant INtratumoral anti-CTLA4 ImmunoTherapy combined with systemic anti-PD-1 (ROCinIT).

Oral Cavity Cancer trials by city

Other conditions